A detailed history of Synovus Financial Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Synovus Financial Corp holds 13,584 shares of TEVA stock, worth $309,307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,584
Previous 13,584 -0.0%
Holding current value
$309,307
Previous $244,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $14,404 - $19,480
-1,350 Reduced 9.04%
13,584 $191,000
Q4 2022

Feb 06, 2023

SELL
$7.95 - $9.48 $1,510 - $1,801
-190 Reduced 1.26%
14,934 $136,000
Q3 2022

Oct 27, 2022

BUY
$6.86 - $11.95 $1,303 - $2,270
190 Added 1.27%
15,124 $122,000
Q3 2021

Nov 08, 2021

SELL
$8.38 - $10.18 $4,114 - $4,998
-491 Reduced 3.18%
14,934 $146,000
Q2 2021

Aug 11, 2021

BUY
$9.9 - $11.56 $178 - $208
18 Added 0.12%
15,425 $153,000
Q1 2021

May 11, 2021

SELL
$10.34 - $12.81 $2,068 - $2,562
-200 Reduced 1.28%
15,407 $177,000
Q4 2020

Feb 11, 2021

BUY
$8.61 - $11.04 $9,703 - $12,442
1,127 Added 7.78%
15,607 $151,000
Q2 2020

Aug 10, 2020

SELL
$8.12 - $13.12 $4,319 - $6,979
-532 Reduced 3.54%
14,480 $179,000
Q1 2020

Apr 24, 2020

SELL
$6.69 - $13.45 $943 - $1,896
-141 Reduced 0.93%
15,012 $135,000
Q4 2019

Feb 06, 2020

SELL
$6.53 - $10.72 $45,579 - $74,825
-6,980 Reduced 31.54%
15,153 $149,000
Q3 2019

Nov 01, 2019

SELL
$6.16 - $9.6 $3,591 - $5,596
-583 Reduced 2.57%
22,133 $151,000
Q2 2019

Aug 08, 2019

SELL
$8.12 - $15.72 $47,623 - $92,197
-5,865 Reduced 20.52%
22,716 $209,000
Q1 2019

May 09, 2019

BUY
$15.58 - $20.01 $934 - $1,200
60 Added 0.21%
28,581 $448,000
Q4 2018

Feb 07, 2019

SELL
$14.59 - $23.84 $15,888 - $25,961
-1,089 Reduced 3.68%
28,521 $441,000
Q3 2018

Nov 01, 2018

BUY
$21.06 - $25.65 $26,704 - $32,524
1,268 Added 4.47%
29,610 $639,000
Q2 2018

Aug 01, 2018

BUY
$16.77 - $24.71 $7,378 - $10,872
440 Added 1.58%
28,342 $688,000
Q1 2018

May 07, 2018

BUY
$16.68 - $22.07 $1,417 - $1,875
85 Added 0.31%
27,902 $475,000
Q4 2017

Feb 09, 2018

BUY
$11.23 - $19.1 $67,705 - $115,153
6,029 Added 27.67%
27,817 $530,000
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $335,753 - $700,919
21,788
21,788 $384,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.